Journal: Thoracic Cancer
Year: 2019
Pages: 10, 918-929
Delanzomib, a novel proteasome inhibitor, sensitizes breast cancer cells to doxorubicin‐induced apoptosis
Distribution of the number of citations over years.

Authors

#AuthorsArticlesCitationsh-index
1Xin Xu1898518
2Yan Niu3656836
3Lin Shen43525043